英文名称:CT26.WT
货号:GCL-0071
价格: ¥1600.00 ¥1600.00
产品详情
产品信息
物种 | Mouse |
生长特性 | 贴壁细胞 |
细胞形态 | 成纤维细胞样 |
冻存条件 |
冻存液:无血清非程序冻存液(GPB180438)/通用血清型程序冻存液(GPB180436) 温度:液氮 |
培养方案A(默认) |
生长培养基:RPMI-1640[GPM150110]+10% FBS[163210]+1% P/S[GPB180120] 培养条件: 温度:37℃ |
推荐传代比例 | 1:3-1:4 |
推荐换液频率 | 2-3次/周 |
参考资料(来源文献)
背景描述 | CT26细胞是以N-亚硝基-N-甲基氨基甲酸酯(NNMU)诱导形成的未分化结肠癌细胞株,它克隆形成的细胞株命名为CT26.WT。用包含编码典型肿瘤相关抗原(TAA)β-半乳糖苷酶(β-gal)的lacZ基因的逆转录病毒载体LXSN稳定转染CT26.WT细胞,得到致死的亚克隆CT26.CL25。即使CT26.CL25细胞表达了典型的TAA-β-半乳糖苷酶,在正常小鼠中CT26.CL25细胞和CT26.WT细胞的生长率与致死率也保持基本一致。CT26.WT细胞与CT26.CL25细胞一起可用作测试免疫治疗程序的模型,并用于研究宿主免疫反应。 |
组织来源 | 器官:结肠;品系:BALB/c;疾病:癌 |
细胞类型 | 肿瘤细胞 |
肿瘤类型 | 肠癌细胞 |
生物安全等级 | BSL-1 |
抗原表达情况 | H-2d |
致瘤性 | Yes, in BALB/c mice. Mice inoculated, subcutaneously, developed lethal tumors at 80% frequency with 1×10³cells and at 100% with 1×10⁴ cells. Pulmonary metastases developed when mice were inoculated, intravenously, with 1×10⁴ cells. |
保藏机构 | ATCC; CRL-2638 BCRC; 60447 |
相关文献
-
Targeted tumor therapy with L-cyst(e)ine-addicted bacteria-nanodrug biohybrids(2025)
期刊:Cell Metabolism
DOI:10.1016/j.cmet.2025.03.012
影响因子:27.7
相关产品: Panc02-luc Cells Line, CT26.WT Cells Line
-
期刊:ADVANCED MATERIALS
影响因子:27.4
-
期刊:Science Bulletin
DOI:10.1016/j.scib.2025.03.015
影响因子:18.8
相关产品: CT26.WT Cells Line, CT26-Luc Cells Line
-
期刊:Nature Communications
DOI:10.1038/s41467-025-55905-y
影响因子:14.7
相关产品: 4T1 Cells Line, MCF7 [MCF-7] Cells Line, PANC-1 Cells Line, B16 Cells Line, CT26.WT Cells Line
-
期刊:CHEMICAL ENGINEERING JOURNAL
影响因子:13.3
相关产品: CT26.WT Cells Line, U-87 MG Cells Line, HT-29 Cells Line, Hela Cells Line, Hep G2 Cells Line, MDA-MB-231 Cells Line
-
期刊:CHEMICAL ENGINEERING JOURNAL
影响因子:13.3
相关产品: Hep G2 Cells Line, HuH-7 Cells Line, H22 Cells Line, CT26.WT Cells Line, Hepa 1-6 Cells Line, 4T1 Cells Line, Hep 3B2.1-7 Cells Line
-
期刊:Cell Reports Medicine
DOI:10.1016/j.xcrm.2024.101913
影响因子:11.7
相关产品: THP-1 Cells Line, CT26.WT Cells Line, SW480 [SW-480] Cells Line, TE-1 Cells Line, HCT 116 Cells Line, B16-F10 Cells Line, 293T [HEK-293T] Cells Line
-
Platelet hitchhiking vascular-disrupting agents for self-amplified tumor-targeting therapy(2025)
期刊:JOURNAL OF NANOBIOTECHNOLOGY
DOI:10.1186/s12951-025-03262-9
影响因子:10.6
相关产品: CT26.WT Cells Line, Human Umbilical Vein Endothelial Cells
-
期刊:JOURNAL OF NANOBIOTECHNOLOGY
DOI:10.1186/s12951-025-03418-7
影响因子:10.6
相关产品: CT26.WT Cells Line, NIH/3T3 Cells Line, 4T1-LUC Cells Line, Hela Cells Line, RAW 264.7 Cells Line, 4T1 Cells Line, Hep G2 Cells Line, MCF-7/ADR Cells Line, U-373 MG Cells Line
-
期刊:Clinical and Translational Medicine
影响因子:7.9
相关产品: CT26.WT Cell Complete Medium, CT26.WT Cells Line, ECL Detection Kit